Los Angeles, CA – November 14, 2025 -   The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce its collaboration with the California Institute of Technology (Caltech) on a newly awarded $2.8 million Discovery Stage Research (DISC0) grant from the California Institute for Regenerative Medicine (CIRM).

Researchers have announced the rediscovery of Moema claudiae, a species of seasonal killifish in Bolivia that was previously thought to be possibly extinct. This rediscovery provides new hope for the conservation of this unique fish and the diverse wetland habitats of the region.

Understanding how the brain learns and applies rules is the key to unraveling the neural basis of flexible behavior. A new study from the University of Toyama, Japan, reveals that our ability to follow procedural rules is encoded in the evolving dynamics of neuronal activity in the medial prefrontal cortex (mPFC).

Patient-derived xenograft (PDX) models are emerging as a transformative tool in colorectal cancer (CRC) research, offering unparalleled insights into tumor biology, drug resistance, and personalized treatment approaches. These models, created by transplanting fresh human tumor tissue into immunodeficient mice, faithfully replicate the genetic, histological, and molecular features of the original tumors. As such, they serve as invaluable resources in the study of tumor heterogeneity and in the development of precision oncology.